Paroxetine is a selective serotonin reuptake inhibitor (SSRI) drug commonly known as Paxil. It has a variety of uses, including the treatment of anxiety disorders, major depression, posttraumatic stress disorder, and symptoms of menopause, among others. It was approved by the FDA in the early 1990s and marketed by SmithKline Beecham. A unique feature of this drug is that it is highly potent and selective in its inhibition of serotonin reuptake and has little effect on other neurotransmitters. Because of its potent inhibition of serotonin reuptake, paroxetine is more likely to cause withdrawal effects upon cessation. Paroxetine is well tolerated in most patients with a similar adverse effect profile to other members of its drug class. The controlled release formulation was designed to decrease the likelihood of nausea that is sometimes associated with paroxetine.
Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder. One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause. Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
FI003, Helsinki, Finland
LT005, Vilnius, Lithuania
EE001, Tallinn, Estonia
Henan mental health center, Xinxiang, Henan, China
Institute of mental health, Peking University, Beijing, Beijing, China
Wuhan mental health center, Wuhan, Hubei, China
Max Planck Institute of Psychiatry, Munich, Bavaria, Germany
Beijing Anding Hospital, Beijing, Beijing, China
Nucleus Network, Melbourne, Victoria, Australia
Forest Investigative Site 001, Miami, Florida, United States
Forest Investigative Site 002, Overland Park, Kansas, United States
Forest Investigative Site 004, Charlottesville, Virginia, United States
Shanghai Mental Health Center, Shanghai, Shanghai, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.